A Global Survey of Potential Acceptance of a COVID-19 Vaccine
By: Jeffrey V. Lazarus, Scott C. Ratzan, Adam Palayew, Lawrence O. Gostin, Heidi J. Larson, Kenneth Rabin, Spencer Kimball & Ayman El-Mohandes
Source: Nature
Several coronavirus disease 2019 (COVID-19) vaccines are currently in human trials. In June 2020, we surveyed 13,426 people in 19 countries to determine potential acceptance rates and factors influencing acceptance of a COVID-19 vaccine. Of these, 71.5% of participants reported that they would be very or somewhat likely to take a COVID-19 vaccine, and 48.1% reported that they would accept their employer’s recommendation to do so. Differences in acceptance rates ranged from almost 90% (in China) to less than 55% (in Russia). Respondents reporting higher levels of trust in information from government sources were more likely to accept a vaccine and take their employer’s advice to do so.
Health for All Ages: Life-course immunization
The benefits of a life-course immunization approach for reaching zero dose-adults, children, and promoting vaccine equity worldwide.
World Refugee Day 2022 Q & A with Silas Ayako
Silas Ayako, Project Clinical Officer, Protection of Refugees and Asylum Seekers at Kenya Red Cross, joins us for a World Refugee Day Q & A.
VARN2022 Conference Report
Findings and insights from the Sabin Vaccine Institute’s inaugural VARN conference
